Guda, Swaroopa
Boston Children's Hospital
2 papers on CoChat
Most cited papers
- Verified
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype.
Brendel, C., Guda, S., Renella, R., Bauer, D. E., Canver, M. C., Kim, Y.-J., Heeney, M. M., Klatt, D., Fogel, J., Milsom, M. D., et al. (2016) · Journal of Clinical Investigation
Hemoglobinopathies and Related DisordersVirus-based gene therapy research
Cited by 167
- Verified
Preclinical evaluation of a novel lentiviral vector driving lineage-specific BCL11A knockdown for sickle cell gene therapy
Brendel, C., Negre, O., Rothe, M., Guda, S., Parsons, G., Harris, C., McGuinness, M., Abriss, D., Tsytsykova, A., Klatt, D., et al. (2020) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchHemoglobinopathies and Related Disorders
Cited by 72
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free